|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1132 GBX | -12.92% |
|
+13.20% | -47.35% |
| 07-07 | WINNERS & LOSERS: Beauty Tech ups guidance; Ixico to beat expectations | AN |
| 07-02 | WINNERS & LOSERS: Capricorn jumps after agreeing to Genel takeover | AN |
| Market Cap | 6.57M 7.52M 6.08M 5.58M 10.56M 725M 10.74M 72.5M 28.48M 354M 28.24M 27.62M 1.22B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 11.44M 13.08M 10.58M 9.7M 18.37M 1.26B 18.69M 126M 49.54M 616M 49.13M 48.05M 2.13B | EV / Sales 2026 * |
6.16x | EV / Sales 2027 * | - |
| Free-Float |
90.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Oxford BioDynamics Plc
| 1 day | -12.92% | ||
| 1 week | +13.20% | ||
| Current month | +13.20% | ||
| 1 month | -35.31% | ||
| 3 months | -49.69% | ||
| 6 months | -57.28% | ||
| Current year | -47.35% |
| 1 week | 0.09 |  | 0.14 |
| 1 month | 0.08 | | 0.18 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.75 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 60.24 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 64 | 2007-06-07 | |
Richard Compton
CEO | Chief Executive Officer | - | 2026-06-29 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 2017-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2007-06-07 | |
Paul Stockdale
BRD | Director/Board Member | - | 2017-09-14 |
David Holbrook
BRD | Director/Board Member | 65 | 2019-04-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/10/25 | Free | Chief Financial Officer | 1,500,000 | 0.0766% | ||
| 11/10/25 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% | ||
| 11/10/25 | Free | Chief Operating Officer | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.92% | +13.20% | -74.96% | -99.05% | 7.52M | |
| -4.70% | -12.68% | +10.66% | -31.60% | 2.97B | |
| -2.16% | -16.03% | -6.26% | -84.02% | 1.82B | |
| +0.53% | +2.84% | -11.15% | -14.39% | 321M | |
| -0.42% | -2.07% | -47.10% | - | 51.17M | |
| Average | -3.93% | -2.98% | -25.76% | -57.27% | 1.03B | |
| Weighted average by Cap. | -3.45% | -12.96% | +2.65% | -49.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86M 2.12M 1.72M 1.58M 2.98M 205M 3.03M 20.47M 8.04M 99.91M 7.97M 7.8M 345M | - |
| Net income | - | - |
| Net Debt | 4.86M 5.56M 4.5M 4.13M 7.81M 536M 7.94M 53.62M 21.06M 262M 20.89M 20.43M 904M | - |
Employees
37
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | GBX 0.1132 | -12.92% | 31,740,477 |
| 26-07-16 | GBX 0.1300 | +23.81% | 29,704,530 |
| 26-07-15 | GBX 0.1050 | 0.00% | 19,161,803 |
| 26-07-14 | GBX 0.1050 | +5.00% | 4,842,191 |
| 26-07-13 | GBX 0.1000 | 0.00% | 17,183,646 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001300GBP
Average target price
0.0100GBP
Spread / Average Target
+669.23%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
